Evidence map›Paper›PMID 29038380›Full record

ReviewPhilosophical transactions. Series A, Mathematical, physical, and engineering sciences2017

Integrating nanomedicine and imaging.

Carlos Pérez-Medina, Sjoerd Hak, Thomas Reiner, Zahi A Fayad, Matthias Nahrendorf, Willem J M Mulder

Open access · bronzeAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Philosophical transactions. Series A, Mathematical, physical, and engineering sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Histochemistry for Molecular Imaging in Nanomedicine.International journal of molecular sciences · 2024
    Review
  3. Article
  4. Active targeted delivery of immune therapeutics to lymph nodes.Current opinion in organ transplantation · 2018
    Review
  5. Challenges for chemistry in molecular imaging.Philosophical transactions. Series A, Mathematical, physical, and engineering sciences · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 3 countries.

Carlos Pérez-MedinaDepartment of Radiology, Icahn School of Medicine at Mount Sinai, Translational and Molecular Imaging Institute, One Gustave L. Levy Place, Box 1234, New York, NY 10029, USA.
Sjoerd HakDepartment of Circulation and Medical Imaging, The Norwegian University of Science and Technology, 7030 Trondheim, Norway.
Thomas ReinerDepartment of Radiology, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
Zahi A FayadDepartment of Radiology, Icahn School of Medicine at Mount Sinai, Translational and Molecular Imaging Institute, One Gustave L. Levy Place, Box 1234, New York, NY 10029, USA.
Matthias NahrendorfCenter for Systems Biology and Department of Imaging, Simches Research Building, 185 Cambridge Street, Boston, MA 02114, USA.
Willem J M MulderDepartment of Radiology, Icahn School of Medicine at Mount Sinai, Translational and Molecular Imaging Institute, One Gustave L. Levy Place, Box 1234, New York, NY 10029, USA willem.mulder@mssm.edu.
Icahn School of Medicine at Mount Sinai · USAcademic Medical Center · NLCornell University · USHarvard University · USNorwegian University of Science and Technology · NO

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Theranostic HDL nanoparticles for inflammatory macrophages in atherosclerosisR01EB009638 · NIBIB · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI FAYAD, ZAHI A. · 2009 to 2016
$4.6M
PET/MRI to study nanotherapy in atherosclerosisR01HL125703 · NHLBI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MULDER, WILLEM · 2015 to 2018
$2.4M
Anti-inflammatory nanoparticle formulations to treat atherosclerosisR01HL118440 · NHLBI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MULDER, WILLEM, NAHRENDORF, MATTHIAS · 2014 to 2017
$2.3M
NCI NIH HHS P30 CA008748NHLBI NIH HHS R01 HL118440NHLBI NIH HHS R01 HL125703NIBIB NIH HHS R01 EB009638
6 · The paper itself

Abstract

Biomedical engineering and its associated disciplines play a pivotal role in improving our understanding and management of disease. Motivated by past accomplishments, such as the clinical implementation of coronary stents, pacemakers or recent developments in antibody therapies, disease management now enters a new era in which precision imaging and nanotechnology-enabled therapeutics are maturing to clinical translation. Preclinical molecular imaging increasingly focuses on specific components of the immune system that drive disease progression and complications, allowing the

Indexed as

AnimalsBiomedical EngineeringDrug DevelopmentHumansMolecular ImagingNanomedicineNanotechnologyPrecision MedicineTranslational Research, Biomedicalbiomedical engineeringmolecular imagingnanomedicinetranslational imaging

Identifiers

PMID29038380
PMCPMC5647268
OpenAlexW2766484242

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.